Leukemia (other) Clinical Trials

Recruiting leukemia (other) studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.

Clinical trials study new ways to prevent, detect, or treat leukemia (other). Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting leukemia (other) studies with sites across the US; use the location tools to find ones near you.

What to expect

Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.

Recruiting leukemia (other) trials

Within

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

for Hematologic Malignancy

Sponsor: Ossium Health, Inc.

Sex: All·Age: 12 - 75

Code: NCT07710781

Rutgers University Study of the Genetics of Blood Cancers

for Blood Cancers

1 site in Piscataway

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18 - 110·Accepts healthy volunteers

Code: NCT07714044

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

for Acute Lymphocytic Leukemia (ALL)

1 site in Pittsburgh

Sponsor: Sawa Ito, MD

Sex: All·Age: 18+

Code: NCT07565220·Phase 1

Apply to this trial

Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia

for Leukemia, Myeloid

2 sites in Boston

Sponsor: Jacqueline Garcia, MD

Sex: All·Age: 18 - 90

Code: NCT07439211·Phase 1

Natural History Study of Early Life Exposures in Agriculture (ELEA)

for Prostate Cancer

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 99·Accepts healthy volunteers

Code: NCT07328516

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

for Core Binding Factor Alpha Subunits

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 4 - 70

Code: NCT07524530·Phase 2

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

for Leukemia

Sponsor: Hematology department of the 920th hospital

Sex: All·Age: 18 - 65

Code: NCT07698080·Phase 2

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

for Acute Leukemia

1 site in Palo Alto

Sponsor: Laguna Biotherapeutics, Inc.

Sex: All·Age: 18 Months - 39

Code: NCT07573111·Phase 1

Pre-malignant States to Hematologic Malignancies in Firefighters

for Clonal Hematopoiesis of Indeterminate Potential

1 site in Charlotte

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 40 - 49·Accepts healthy volunteers

Code: NCT06870760

Apply to this trial

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

for Leukemia

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT07405424

Apply to this trial

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

for Leukemia

1 site in Chapel Hill

Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All·Age: 6+·Accepts healthy volunteers

Code: NCT07634653

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

for Leukemia

1 site in Columbus

Sponsor: Hannah Choe, MD

Sex: All·Age: 18+

Code: NCT07249346·Phase 2

Apply to this trial

CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma

for Lymphoma

Sponsor: Qi deng

Sex: All·Age: 14 - 75

Code: NCT07383233·Phase 1

Weight Gain in Pediatric Leukemia Survivors

for Leukemia

1 site in St Louis

Sponsor: Washington University School of Medicine

Sex: All·Age: 6+

Code: NCT07374315

Cohort of Patients With Chronic Myelomonocytic Leukemia

for Leukemia

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Sex: All·Age: 18+

Code: NCT07512882

Apply to this trial

Clonal Hematopoiesis of Immunological Significance

for Immune System Diseases

Sponsor: Assistance Publique - Hôpitaux de Paris

Sex: All·Age: 18+

Code: NCT05969821

ALL Backbone in AYAs

for Acute Lymphoblastic Leukemia

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18 - 51

Code: NCT07227584·Phase 2

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

for Acute Myelogenous Leukemia

1 site in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: Up to 26

Code: NCT07566377·Phase 2

Apply to this trial

MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

for AML

1 site in Minneapolis

Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All·Age: 2 - 75

Code: NCT07493538·Phase 2

Apply to this trial

Halt Aging in Survivors of Blood Cancers

for Hematological Malignancy

1 site in Omaha

Sponsor: University of Nebraska

Sex: All·Age: 50+

Code: NCT07292272

Apply to this trial

Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis

for Acute Leukemia

Sponsor: Centre Henri Becquerel

Sex: All·Age: 26 - 80

Code: NCT07499765

Apply to this trial

HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

for Acute Lymphoblastic Leukemia

Sponsor: The Children's Hospital of Zhejiang University School of Medicine

Sex: All·Age: 1 - 21

Code: NCT07483749

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

for Leukemia

1 site in Chicago

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT07294677·Phase 1, Phase 2

Apply to this trial

BY002 IIT Study in R/R Acute Leukemia

for Acute Leukemia

Sponsor: The First Affiliated Hospital of Soochow University

Sex: All·Age: 16+

Code: NCT07270770·Phase 1

Apply to this trial

Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies

for Hodgkin Disease

1 site in Milwaukee

Sponsor: Medical College of Wisconsin

Sex: All·Age: 18+

Code: NCT05544968·Phase 1

Apply to this trial

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

for Leukemia

1 site in Bethesda

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 120·Accepts healthy volunteers

Code: NCT06856226

Apply to this trial

A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax

for Acute Myeloid Leukaemia (AML)

2 sites in Boston

Sponsor: Jacqueline Garcia, MD

Sex: All·Age: 18+

Code: NCT07148180·Phase 1, Phase 2

Apply to this trial

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

for Acute Leukemia

Sponsor: Actinium Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07157514·Phase 2, Phase 3

A Study of Revumenib and Mezigdomide in People With Leukemia

for Leukemia

10 sites incl. Duarte

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 12+

Code: NCT07356154·Phase 1, Phase 2

Apply to this trial

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for Leukemia, Myeloid, Acute

6 sites incl. Los Angeles

Sponsor: Orca Biosystems, Inc.

Sex: All·Age: 18+

Code: NCT07216443·Phase 2

Apply to this trial

Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever

for Leukemia

Sponsor: Peter MacCallum Cancer Centre, Australia

Sex: All·Age: 18+

Code: NCT07051525

Apply to this trial

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

for Acute Myeloid Leukemia

1 site in Palo Alto

Sponsor: Stanford University

Sex: All·Age: 18 - 70

Code: NCT06551584·Phase 1

Apply to this trial

Mosunetuzumab for CLL MRD Clearance

for Leukemia

2 sites in Boston

Sponsor: Inhye Ahn

Sex: All·Age: 18+

Code: NCT07052695·Phase 1, Phase 2

Apply to this trial

A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT

for Menin Inhibitors

Sponsor: The First Affiliated Hospital of Soochow University

Sex: All·Age: 15+

Code: NCT07559695

Apply to this trial

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

for Relapsed or Refractory Hematologic Malignancies

Sponsor: Biotroy Therapeutics

Sex: All·Age: 18 - 70

Code: NCT07107204·Phase 1, Phase 2

Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

for Acute Leukemia

Sponsor: Zhujiang Hospital

Sex: All·Age: 18 - 70

Code: NCT07362095·Phase 1, Phase 2

Apply to this trial

A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction

for Leukemia, B-Cell, Chronic

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Sex: All·Age: 70+

Code: NCT07082452·Phase 3

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

for Acute Myeloid Leukemia

1 site in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06928662·Phase 1, Phase 2

Apply to this trial

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects

for COPD

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06800586

Apply to this trial

HEME Home Transfusion Program

for Leukemia

2 sites in Boston

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06487247

Apply to this trial

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

for Leukemia

Sponsor: Princess Maxima Center for Pediatric Oncology

Sex: All·Age: 1 - 45

Code: NCT07020260·Phase 1, Phase 2

Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia

for Acute Leukemia

Sponsor: Ruijin Hospital

Sex: All·Age: 18+

Code: NCT07087847

Bleeding and Thrombotic Risk Prediction in Acute Leukemia: Clinical Utility of the Siriraj Acute Myeloid/Lymphoblastic Leukemia (SiAML) Score Versus Established Hemostatic Tools

for Acute Leukemia

Sponsor: Assiut University

Sex: All·Age: 18+

Code: NCT07108686

Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies

for Leukemia

Sponsor: The First Affiliated Hospital of Xinxiang Medical College

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07131449

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

for Leukemia

Sponsor: First Affiliated Hospital of Zhejiang University

Sex: All·Age: 14 - 65

Code: NCT07105579·Phase 2

Apply to this trial

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

for Leukemia

Sponsor: Anhui Provincial Hospital

Sex: All·Age: 14+

Code: NCT07120607·Phase 1

Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia

for Menin Inhibitors

Sponsor: The First Affiliated Hospital of Soochow University

Sex: All·Age: 12+

Code: NCT07101497·Phase 2

Apply to this trial

Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia

for Acute Lymphobkastic Leukemia

Sponsor: Hospital General de Mexico

Sex: All·Age: 18+

Code: NCT07258043

Apply to this trial

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

for Acute Myeloid Leukemia

6 sites incl. Baltimore

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06824168·Phase 2

Apply to this trial

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

for Leukemia

Sponsor: Azienda USL Reggio Emilia - IRCCS

Sex: All·Age: 18 - 99

Code: NCT06795815

Apply to this trial

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

for Blood Cancer

7 sites incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07052916

Apply to this trial

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

for Lymphoma

3 sites incl. Los Angeles

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 5+·Accepts healthy volunteers

Code: NCT05237986

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

9 sites incl. Duarte

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2

Apply to this trial

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

for Leukemia

1 site in Memphis

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: Up to 25

Code: NCT06810583·Phase 1

Apply to this trial

Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

for Myelodysplastic Syndrome

Sponsor: Peking University People's Hospital

Sex: All·Age: 12 - 65

Code: NCT06984536·Phase 2

Apply to this trial

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

for Acute Myeloid Leukemia

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Sex: All·Age: 1 Month - 25

Code: NCT07256210·Phase 2

Apply to this trial

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

for Myeloma

Sponsor: Monash University

Sex: All·Age: 18+

Code: NCT07202078·Phase 2, Phase 3

Apply to this trial

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

for Myeloma

Sponsor: Monash University

Sex: All·Age: 18+

Code: NCT07202052·Phase 2, Phase 3

Apply to this trial

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

for Myeloma

Sponsor: Monash University

Sex: All·Age: 18+

Code: NCT07202091·Phase 2, Phase 3

Apply to this trial

Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

for Leukemia

Sponsor: Peking University First Hospital

Sex: All·Age: 18+

Code: NCT06895538

Apply to this trial

Leukemia (other) clinical trials — common questions

Are leukemia (other) clinical trials free to join?

Yes. Participating in a leukemia (other) clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.

Who can join a leukemia (other) clinical trial?

Each leukemia (other) study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.

How do I find a leukemia (other) trial near me?

Use the location controls above. We'll show recruiting leukemia (other) trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.

How many leukemia (other) trials are recruiting right now?

We're currently tracking roughly 86 recruiting leukemia (other) trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.

Looking for a specific location? Browse trials by city and state.

Leukemia (other) trials by city

Boston, MA Duarte, CA Seattle, WA Birmingham, AL Los Angeles, CA Aurora, CO Chicago, IL Palo Alto, CA Milwaukee, WI Omaha, NE San Diego, CA Cincinnati, OH

Related specialties

Oncology Blood cancer